Steer clear of or substitute One more drug for these medications when feasible. Appraise for loss of therapeutic influence if medication need to be coadministered. Regulate dose In accordance with prescribing information and facts if necessary.ergotamine will raise the amount or impact of tazemetostat by influencing hepatic/intestinal enzyme CYP3A4